On May, 29 Analysts See $-0.01 EPS for ICC Labs Inc. (ICC)

May 16, 2018 - By Patrick Harkless

On May, 29 WallStreet awaited ICC Labs Inc. (CVE:ICC)’s earnings release, according to Faxor. Analysts forecast $-0.01 earnings per share. That’s $0.00 or 0.00 % from 2017’s earnings of $-0.01. ICC hit $1.34 during the last trading session after $0.03 change.Currently ICC Labs Inc. is after 0.00% change in last May 17, 2017. ICC has also 76,382 shares volume. ICC underperformed the S&P 500 by 11.55%.

ICC Labs Inc. produces and sells cannabis in Uruguay.The company has $184.98 million market cap. It offers recreational cannabis, cannabinoid extracts, and by-products for medicinal use, as well as industrial hemp.Last it reported negative earnings. The firm was formerly known as ICC International Cannabis Corporation and changed its name to ICC Labs Inc. in December 2017.

There’s a substantial ICC Labs Inc. (CVE:ICC) news announced by Midasletter.com. It’s a report titled: “Canada Cannabis Roundup: ICC Labs, Choom, Delta 9 Cannabis, Hiku, WeedMD, Indiva, Golden Leaf Holdings” on April 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.